Abstract
Introduction During the first wave of COVID-19 it was hypothesized that COVID-19 is subject to multi-wave seasonality, such as other respiratory viral infections since time immemorial, including earlier respiratory pandemics. It has already been observed that the COVID-19 community outbreaks appear to have a similar pattern as other influenza like illnesses (ILI). One year into the pandemic, we aimed to test the seasonality hypothesis for COVID-19.
Methods We gather and calculated the average ILI annual time series based on incidence data from 2016 till 2019 in the Netherlands. And, compared this with two independent COVID-19 time series during 2020/2021 for the Netherlands, plotted on a logarithmic infection scale. We tested our hypothesis by calculating correlation coefficients and, as a sensitivity analysis, by performing univariate regression analysis.
Results The COVID-19 time series strongly and highly significantly correlates with the ILI time series r(45) = 0.75 (p < 0.00001) and (r(45) = 0.798, p < 0.00001). Also the univariate regression analyses that we performed as a sensitivity analysis are all highly significant: respectively F(1, 43) = 61.45, p < 0.0001, and F(1, 43) = 81.18, p < 0.0001 and the correlations (r2) are moderate to strong.
Conclusions Given the strong, and highly significant, correlations between the ILI and COVID-19 time series, we conclude that COVID-19 behaves as seasonal as ILI in a country in the temperate climate zone, such as the Netherlands. Moreover, the COVID-19 peaks are all during flu season, and lows are all in the opposing period as expected. Furthermore, the COVID-19 time series satisfies the two characteristics of earlier pandemics, namely a short first wave at the tail-end of a flu season, and a longer and more intense second wave during the subsequent flu season.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
N/A
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data is fully based on publicly available sources.
